drugset / Trial / NCT01634230

Emergency Use of OCR-002 in Acute Liver Failure (ALF)

NCT01634230 ↗

Expanded access No longer available Ocera Therapeutics

Summary

This study provides emergency use of the unapproved study medication in ALF patients with acute liver failure who are not responding to standard of care.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornithine Phenylacetate Unknown 10 g —

Indications